Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT

Table 13 Text report of 50% rise in the cost of Amoxicillin

P1	Strategy	Cost	Incr Cost	Eff	Incr Eff	C/E	Incr C/E (ICER)
0.2	RDT	$356,389		99,953		$4
	PT	$390,737	$34,348	99,662	291	$4	$118
	M	$415,001		99,938		$4	(Dominated)
0.3	RDT	$357,353		99,951		$4
	PT	$378,081	$20,728	99,699	253	$4	$82
	M	$415,249		99,937		$4	(Dominated)
0.4	RDT	$358,316		99,950		$4
	PT	$365,426	$7,109	99,735	214	$4	$33
	M	$415,496		99,935		$4	(Dominated)
0.5	PT	$352,770		99,772		$4
	RDT	$359,280		99,948		$4	(Dominated)
	M	$415,744		99,934		$4	(Dominated)
0.6	PT	$340,114		99,808		$3
	RDT	$360,243		99,946		$4	(Dominated)
	M	$415,991		99,933		$4	(Dominated)

ISSN: 1475-2875